BUSCH, Sarah A.,HORN, Kevin P.,MAYS, Robert W.,SILVER, Jerry
申请号：
AU2014280897
公开号：
AU2014280897B2
申请日:
2014.12.23
申请国别(地区):
AU
年份:
2016
代理人:
摘要：
#$%^&*AU2014280897B220160929.pdf#####ABSTRACT A method for treating spinal cord injury that is associated with axonal retraction includes administering pharmaceutically active ingredients consisting of stem cells in sufficient proximity to the injury, for time sufficient, and in sufficient amount, to secrete factors therefrom that reduce axonal retraction and reduce spinal cord injury that is associated with said axonal retraction, wherein the stem cells are non-embryonic stem cells that have the ability to differentiate into cell types of more than one embryonic germ layer and/or express one or more of oct4, telomerase, rex-1, rox-1, sox-2, and SSEA4. I1 /1IA
